🇺🇸 Bisphosphonate therapy in United States

5 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Gastrointestinal Perforation — 1 report (20%)
  2. General Physical Health Deterioration — 1 report (20%)
  3. Hypercalcaemia — 1 report (20%)
  4. Leukaemia Plasmacytic — 1 report (20%)
  5. Pancytopenia — 1 report (20%)

Source database →

Bisphosphonate therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Bisphosphonate therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Bisphosphonate therapy in United States?

Ondokuz Mayıs University is the originator. The local marketing authorisation holder may differ — check the official source linked above.